1. Home
  2. UCTT vs TNGX Comparison

UCTT vs TNGX Comparison

Compare UCTT & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultra Clean Holdings Inc.

UCTT

Ultra Clean Holdings Inc.

HOLD

Current Price

$86.11

Market Cap

4.8B

Sector

Technology

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$29.13

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCTT
TNGX
Founded
1991
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.5B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
UCTT
TNGX
Price
$86.11
$29.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$97.33
$21.78
AVG Volume (30 Days)
1.4M
2.2M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.89
EPS
N/A
N/A
Revenue
$1,734,500,000.00
$62,384,000.00
Revenue This Year
$19.18
N/A
Revenue Next Year
$17.36
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.29
52 Week Low
$21.49
$6.21
52 Week High
$144.22
$34.39

Technical Indicators

Market Signals
Indicator
UCTT
TNGX
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
UCTT
TNGX

About UCTT Ultra Clean Holdings Inc.

Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments: Products and Services. Its principal markets are the Americas, Asia Pacific, and EMEA.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: